Newsroom Ready: Carney meets with energy sector
Prime Minister Mark Carney met with oil and gas executives in Calgary to get their input for his plans to make Canada an energy superpower. Carney, in his first visit to Calgary since being sworn in as prime minister, sat down for a closed door roundtable with several representatives of the energy sector. (June 1, 2025)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
an hour ago
- Associated Press
Quantum BioPharma Clarifies It Has Not Changed Its Name
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ('Quantum BioPharma'), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces its response to information about certain stock trading platforms as well as misinformation being circulated on certain social media channels. Certain stock trading platforms mistakenly have the Quantum BioPharma name changed to Unbuzzd Wellness Inc. (formerly, Celly Nutrition Corp.) after the news release was issued on May 29, 2025. Quantum BioPharma has not changed its name. In addition, it has been brought to the attention of Quantum BioPharma that misinformation is being circulated on certain social media channels that Unbuzzd Wellness Inc., the company behind unbuzzd™, the scientifically-proven product that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms, is doing a reverse takeover transaction ('RTO') into Quantum BioPharma. Currently Unbuzzd Wellness Inc. is not doing a RTO transaction with Quantum BioPharma. Unbuzzd Wellness Inc. has hired leading audit firm MNP LLP ('MNP') effective May 20, 2025, to conduct Public Company Accounting Oversight Board ('PCAOB') audits of the Company's financial statements in preparation for a possible initial public offering ('IPO'). MNP, registered with the PCAOB, has the experience and proven track record to deliver audits of the highest standard. Hiring MNP follows the Company's announcement on February 5, 2025, regarding their retention of a New York investment bank to advise on a capital raise and explore an IPO, pending regulatory approval. Financial terms between Quantum BioPharma and Unbuzzd Wellness Inc. Currently Quantum BioPharma is the largest shareholder and debt holder of Unbuzzd Wellness Inc. Pursuant to the terms of their Agreement, Quantum will receive a 7% royalty on revenue from Unbuzzd Wellness Inc., until a total in the amount of $250,000,000 has been paid to Quantum, at which point the rate is reduced to 3%. In addition, Unbuzzd Wellness Inc. had issued Quantum 200,000,000 post-split common shares in the capital of the Unbuzzd Wellness Inc. ('Common Shares') as a licence fee and has issued Quantum an anti-dilution warrant, entitling Quantum to exercise the warrant any point in the next three years to increase their holding in the company to 25% for nominal consideration. On a go-public transaction, Quantum BioPharma will own at least 25% of Unbuzzd Wellness Inc. Unbuzzd Wellness Inc. and Quantum entered into a loan agreement, whereby Quantum loaned the Company $1,300,000 on secured basis with a term of 3 years, which will bear interest at a rate of 10% per annum, payable on each anniversary. Unbuzzd Wellness Inc.'s leadership team brings unparalleled experience and expertise to the table. The company is led by CEO John Duffy, a seasoned executive with a distinguished career at Coca-Cola Enterprises and The Coca-Cola Company. Duffy's vision is further complemented by the strategic guidance of beverage industry luminary and Unbuzzd Wellness Inc. Board Co-Chair Gerry David, the former CEO of Celsius Holdings, Inc., who played a pivotal role in establishing Celsius as a leading name in the beverage industry. Debt Settlement The Company also announces an authorized debt settlement for two vendors totaling USD$20,930 with Class B Shares that the board of directors of the Company (the 'Board') authorized. The Company intends to complete the Debt Settlements in or around the first week of June 2025. About Quantum BioPharma Ltd. Quantum BioPharma (NASDAQ: QNTM) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. ('Lucid'), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented unbuzzd™ and spun out its OTC version to a company, Unbuzzd Wellness Inc. (formerly Celly Nutrition Corp.), led by industry veterans. Quantum BioPharma retains ownership of 20.11% (as of March 31, 2025) of Unbuzzd Wellness Inc. The agreement with Unbuzzd Wellness Inc. also includes royalty payments of 7% of sales from unbuzzd™ until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property. For more information on Quantum BioPharma, please visit About Unbuzzd Wellness Inc. The Company, a non-trading but fully reporting public issuer, stands as a pioneering force in the wellness and recovery supplement landscape. unbuzzd has been developed by a world-class research and development team in pharmacology and medicine, with a commitment to innovation and quality. With a proprietary blend of vitamins, minerals and herbs, unbuzzd helps your body process alcohol faster, restore mental alertness, and improve cognition so you can drink responsibly. unbuzzd appeals to a broad audience of alcohol consumers who want to have a good time, be in control, and still feel great the next day. Scientifically-backed by a recently completed double-blind, randomized, placebo-controlled crossover design clinical trial, unbuzzd dramatically accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, restores mental clarity, and reduces the symptoms of intoxication, impairment and hangover. The full press release of the clinical trial can be found here. unbuzzd ready-to-mix powder sticks are available in 3-pack, 8-pack, and 18-pack formats at and unbuzzd is a registered trademark of the Company. Individual results may vary. unbuzzd is a dietary supplement. Consuming unbuzzd after alcohol ingestion does not permit you to operate a vehicle. Drink responsibly. DO NOT DRINK AND DRIVE. For more information on Unbuzzd Wellness Inc. please visit Forward-Looking Information Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as 'may', 'should', 'anticipate', 'expect', 'potential', 'believe', 'intend' or the negative of these terms and similar expressions. Forward-looking statements in this news release include statements related to such. Forward-looking information in this press release are based on certain assumptions and expected future events. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to additional information relating to Quantum BioPharma, including its annual information form, can be located on the SEDAR+ website at and on the EDGAR section of the United States Securities and Exchange Commission's website a more complete discussion of such risk factors and their potential effects. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those Quantum BioPharma Ltd. Zeeshan Saeed, Founder, CEO and Executive Co-Chairman of the Board Email: [email protected] Telephone: (833) 571-1811 Investor Relations Investor Relations: [email protected] General Inquiries: [email protected]
Business Wire
an hour ago
- Business Wire
X-energy Receives ISO-9001 Quality Management System Certification
ROCKVILLE, Md.--(BUSINESS WIRE)--X-Energy Reactor Company, LLC ("X-energy" or the "Company"), a leading developer of advanced nuclear reactors and fuel technology, announced today that it has received ISO 9001 certification for its quality management system (QMS). ISO 9001 is the globally recognized standard for quality management, providing guidelines that help ensure consistent high-quality service and product delivery across a variety of industries. ISO 9001 helps us build and maintain the highest standard of quality assurance and reinforce a culture of innovation that further demonstrates our continued preparation to reliably deploy our technology at scale. "This certification underscores X-energy's commercial readiness, the industry-leading strength of our team, and the steps we're taking to deploy our technology on time and on budget,' said J. Clay Sell, X-energy's Chief Executive Officer. 'ISO 9001 helps us build and maintain the highest standard of quality assurance and reinforce a culture of innovation that further demonstrates our continued preparation to reliably deploy our technology at scale.' X-energy received certification from Bureau Veritas, a global leader in testing, inspection, and certification services, following an extensive audit of the company's internal processes for engineering, design, auditing, and surveys for advanced nuclear reactor design and development. The review resulted in an unqualified recommendation for certification, noting a high level of excellence in execution in the company's existing systems, and identifying best practices in the areas of internal auditing, performance monitoring, and management review, where X-energy greatly exceeded baseline requirements. X-energy is advancing its initial Xe-100 plant at Dow Inc.'s UCC Seadrift Operations manufacturing site on the Texas Gulf Coast. Once complete, the plant is expected to provide the site with safe, reliable, and clean power and industrial steam. X-energy is also working with Energy Northwest and Amazon to construct a second Xe-100 plant in Richland, Washington. This project is the first step in a collaboration with Amazon to bring more than five gigawatts of new power projects online by 2039, furthering the company's mission to provide scalable, secure, clean energy solutions that meet the growing demand for energy across the U.S. and around the world. About X-Energy Reactor Company, LLC X-Energy Reactor Company, LLC, is a leading developer of advanced small modular nuclear reactors and fuel technology for clean energy generation that is redefining the nuclear energy industry through its development of safer and more efficient advanced small modular nuclear reactors and proprietary fuel to deliver reliable, zero-carbon and affordable energy to people around the world. X-energy's simplified, modular, and intrinsically safe SMR design expands applications and markets for deployment of nuclear technology and drives enhanced safety, lower cost and faster construction timelines when compared with other SMRs and conventional nuclear. For more information, visit or connect with us on Twitter or LinkedIn.
E&E News
an hour ago
- E&E News
Mike Lee seeks to reinstate public lands sales in megabill
Senate Energy and Natural Resources Chair Mike Lee wants to revive public lands sales axed last month from the Republican tax, energy and security spending megabill. POLITICO's E&E News asked the Utah Republican Monday whether he intended to bring back public lands provisions that were cut from the House package. Lee, who was on his way to a procedural vote on a Defense department nominee, responded, 'I gotta go vote, but yes.' Last month, following a protracted intraparty battle, House leaders stripped the sale or transfer of nearly half a million acres in Nevada and Utah from the 'one, big, beautiful bill.' Advertisement The bill is now awaiting action in the Senate, where senators will retool it and return it to the House. POLITICO reported Monday that Senate committees, including Environment and Public Works, plan to begin releasing text as early as this week. Lee has long railed against federal ownership of lands in Western states. He frequently points out that roughly two-thirds of land in Utah is federally owned. On Monday, he did not elaborate on the details of what he plans to reintroduce. Lee's plans could add a major hurdle into the upper chamber's race to pass their version of the bill to unlock President Donald Trump's domestic agenda by July 4. Public lands sales are caustic to some members of the Senate like Sen. Steve Daines (R-Mont.), who has vowed to never vote for the sale of public lands. Senate Republicans can only afford to lose three votes on the legislation, which is being passed via budget reconciliation — a parliamentary measure that allows them to skirt the Senate's 60-vote filibuster. The return of public lands sales would also reignite anger from Democrats and public lands advocates, who have long worried about Lee's intentions. 'If Sen. Lee tries to reinsert public lands selloff provisions in the Senate bill, it shows just how out of touch he is with what Western Americans and Americans across the country want,' said Michael Carroll, public lands campaign director at the Wilderness Society, in an interview. 'Congress stripped that provision out of the budget bill and now it looks like this provision's going to have to get taken out of the Senate bill if and when Sen. Lee decides to move forward.' Public lands sales first entered the House reconciliation bill through a committee amendment from Reps. Mark Amodei (R-Nev.) and Celeste Maloy (R-Utah). Amodei and Maloy argued the amendment was carefully tailored to address housing needs, but opponents warned it would set a precedent that public lands can be sold any time Congress needs to raise revenues. The language was stripped by House leadership just hours before the vote after a push from Rep. Ryan Zinke (R-Mont.), Trump's first Interior secretary. He had threatened to vote against the whole bill unless the provision was removed.
